Evidence map›Paper›PMID 35792753›Full record

ArticleBioscience reports2022

TCF7 is highly expressed in immune cells on the atherosclerotic plaques, and regulating inflammatory signaling via NFκB/AKT/STAT1 signaling.

Zhongnan Ma, Chuang Wang, Xiufeng Bai, Long Wang, Qianjing Wu, Zehong Cai, Wanxiang Wang, Zhuo Ma, Xinyu Liu, Jiaxuan Feng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Oxidized LDL Induces Pro-Inflammatory Transcriptomic and Epigenomic Responses in Human CD4FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zhongnan MaDepartment of Vascular Surgery, Intervention Center, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.ORCID 0000-0003-1457-0330
Chuang WangDepartment of Laboratory of Human Diseases and Immunotherapies, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Xiufeng BaiDepartment of Laboratory of Human Diseases and Immunotherapies, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Long WangDepartment of Research & Development, GenEros BioPharma Ltd., Hangzhou 310018, China.
Qianjing WuDepartment of Research & Development, GenEros BioPharma Ltd., Hangzhou 310018, China.
Zehong CaiDepartment of Research & Development, GenEros BioPharma Ltd., Hangzhou 310018, China.
Wanxiang WangDepartment of Research & Development, GenEros BioPharma Ltd., Hangzhou 310018, China.
Zhuo MaDepartment of Biology, China Pharmaceutical University, Nanjing 210009, China.
Xinyu LiuDepartment of Research & Development, GenEros BioPharma Ltd., Hangzhou 310018, China.
Jiaxuan FengDepartment of Vascular Surgery, Intervention Center, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
Rui FengDepartment of Vascular Surgery, Intervention Center, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
China Pharmaceutical University · CNShanghai Jiao Tong University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis, which is the fundamental basis for cardiovascular diseases in the global world, is driven by multiple roles of the immune system in the circulation and vascular plaque. Recent studies demonstrated that T-cell infiltrates into aorta plaque and plays an important role in recruiting macrophages to the vascular wall. Here, using single-cell sequencing, we found T cells in patients' plaques and differentially expressed genes (DEGs) of T cells in atherosclerosis mice. T cells and macrophages were continuously activated in atherosclerotic plaque in patients. Besides, other immune cells also take part in atherogenesis, such as natural killer (NK) cells, granulocytes. Interferon (IFN)/NFκB signaling, the AKT signaling pathway was highly activated in mouse (in vivo) and cell line (in vitro). TCF7 and XCL1 were regulated by AKT and NFκB, respectively through protein-protein network analysis. Therefore, we attempt to clarify and discover potential genes and new mechanisms associated with atherosclerosis for drug development.

Indexed as

AtherosclerosisPlaque, AtheroscleroticAnimalsHepatocyte Nuclear Factor 1-alphaMiceNF-kappa BProto-Oncogene Proteins c-aktSignal TransductionSTAT1 Transcription FactorHepatocyte Nuclear Factor 1-alphaHnf1a protein, mouseNF-kappa BProto-Oncogene Proteins c-aktStat1 protein, mouseSTAT1 Transcription FactorAtherosclerosisinflammationTCF7XCL1

Identifiers

PMID35792753
PMCPMC9297684
OpenAlexW4283826867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.